On 2025-05-07, Apellis Pharmaceuticals, Inc. (APLS) announced earnings per share of $-0.74 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.36.
The next expected annoucement date for quarterly earnings is 2025-08-07, with an average estimated earnings per share of $-0.43 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-07 | 2025-03-31 | $-0.36 | $-0.74 |
| 2025-02-28 | 2024-12-31 | $-0.39 | $-0.29 |
| 2024-11-05 | 2024-09-30 | $-0.32 | $-0.46 |
| 2024-08-01 | 2024-06-30 | $-0.33 | $-0.28 |
| 2024-05-07 | 2024-03-31 | $-0.54 | $-0.54 |
| 2024-02-27 | 2023-12-31 | $-0.66 | $-0.73 |
| 2023-11-01 | 2023-09-30 | $-0.84 | $-1.17 |
| 2023-07-31 | 2023-06-30 | $-1.35 | $-1.02 |
| 2023-05-04 | 2023-03-31 | $-1.42 | $-1.56 |
| 2023-02-21 | 2022-12-31 | $-1.65 | $-1.50 |
| 2022-11-07 | 2022-09-30 | $-1.48 | $-1.75 |
| 2022-08-08 | 2022-06-30 | $-1.43 | $-1.46 |
| 2022-05-04 | 2022-03-31 | $-1.36 | $-1.42 |
| 2022-02-28 | 2021-12-31 | $-1.32 | $-1.61 |
| 2021-11-08 | 2021-09-30 | $-1.73 | $-2.28 |
| 2021-08-09 | 2021-06-30 | $-1.70 | $-2.72 |
| 2021-04-28 | 2021-03-31 | $-1.69 | $-2.32 |
| 2021-02-25 | 2020-12-31 | $-0.48 | $0.93 |
| 2020-11-02 | 2020-09-30 | $-1.53 | $-1.79 |
| 2020-07-31 | 2020-06-30 | $-1.30 | $-1.57 |
| 2020-04-29 | 2020-03-31 | $-1.33 | $-2.29 |
| 2020-02-27 | 2019-12-31 | $-1.15 | $-1.70 |
| 2019-11-05 | 2019-09-30 | $-1.04 | $-1.10 |
| 2019-07-31 | 2019-06-30 | $-0.80 | $-0.98 |
| 2019-05-08 | 2019-03-31 | $-0.72 | $-0.87 |
| 2019-02-26 | 2018-12-31 | $-0.65 | $-0.65 |
| 2018-11-13 | 2018-09-30 | $-0.63 | $-0.64 |
| 2018-07-31 | 2018-06-30 | $-0.41 | $-0.61 |
| 2018-04-30 | 2018-03-31 | $-0.27 | $-0.43 |
| 2018-03-19 | 2017-12-31 | $-0.27 | $-0.60 |